Discovery of Plasma Lipids as Potential Biomarkers Distinguishing Breast Cancer Patients from Healthy Controls
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.A new blood test using a 20-lipid signature from plasma shows promise for early breast cancer detection. This approach achieved high accuracy, potentially improving cancer screening and patient outcomes.
Area Of Science
- Biochemistry
- Oncology
- Analytical Chemistry
Background
- Early breast cancer detection is vital for improving patient outcomes.
- Mammography has limitations, driving the need for alternative screening methods.
- Circulating factors in blood offer potential biomarkers for cancer detection.
Purpose Of The Study
- To develop a sensitive and specific blood test for early breast cancer detection.
- To identify a plasma-derived lipid biomarker signature for distinguishing breast cancer patients from healthy individuals.
Main Methods
- Utilized liquid chromatography with high-resolution and tandem mass spectrometry (LC-MS/MS) to identify plasma lipids.
- Developed a 20-lipid signature using a random forest feature selection algorithm.
- Employed ensemble machine learning models for performance evaluation.
Main Results
- The plasma 20-lipid signature demonstrated high diagnostic accuracy.
- Achieved an area under the curve (AUC) of 0.95.
- Reported a sensitivity of 0.91 and specificity of 0.79 for breast cancer detection.
Conclusions
- Plasma-derived lipids can serve as effective biomarkers for early-stage breast cancer detection.
- The developed lipid signature shows potential for a novel blood-based breast cancer assay.
- Further development of this assay could enhance breast cancer screening strategies.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.